EyePoint Pharmaceuticals, Inc.EYPTNASDAQ

52-Week Range4-19

3.91Current 13.4519.11

Want to monitor EYPT?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

EYP-1901 is a potential twice-yearly sustained delivery intravitreal anti-VEGF treatment for wet age-related macular degeneration.

Manufacturing

Analytical Laboratory Instrument Manufacturing

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Why PROG Holdings (PRG) is a Great Dividend Stock Right Now

Why Toronto-Dominion Bank (TD) is a Great Dividend Stock Right Now

Goldman Sachs (GS) is a Top Dividend Stock Right Now: Should You Buy?

Why Union Pacific (UNP) is a Great Dividend Stock Right Now

Wells Fargo (WFC) Could Be a Great Choice

Micron stock slips 5% after earnings: should you buy the dip?

Red Cat Holdings: No Formal Guidance, Big Selloff - I Loaded The Truck

Tesla targets December 2026 for next-generation AI6 chip tape-out

AGRO or CTVA: Which Is the Better Value Stock Right Now?

ALSN vs. RACE: Which Stock Is the Better Value Option?

BTSG or ALHC: Which Is the Better Value Stock Right Now?

AXS vs. WRB: Which Stock Is the Better Value Option?

ALGN or WST: Which Is the Better Value Stock Right Now?

DECK vs. IDEXY: Which Stock Is the Better Value Option?

USFD vs. CELH: Which Stock Is the Better Value Option?

DRH or EGP: Which Is the Better Value Stock Right Now?

MGNI vs. BL: Which Stock Is the Better Value Option?

ACV Expands MAX Suite, Delivers AI-Powered, Profit-Focused Inventory Guidance with New ACV MAX Recommendations Feature

Why Is Louisiana-Pacific (LPX) Down 12.9% Since Last Earnings Report?

About